An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival

BACKGROUND: In 2016, the World Health Organization reclassified the definition of glioblastoma (GBM), dividing these tumors into isocitrate dehydrogenase (IDH)-wild-type and IDH-mutant GBM, where the vast majority of GBMs are IDH-wild-type. Nomograms are useful tools for individualized estimation of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Adv
Autors principals: Gittleman, Haley, Cioffi, Gino, Chunduru, Pranathi, Molinaro, Annette M, Berger, Mitchel S, Sloan, Andrew E, Barnholtz-Sloan, Jill S
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Basic and Translational Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6777501/
https://ncbi.nlm.nih.gov/pubmed/31608326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars